NeRRe Therapeutics Company
NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.
Headquarters:
Stevenage, Herefordshire, United Kingdom
Industry:
PharmTech
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
7
Investment Stage:
N/A
Investor Type:
Company
Funding Status:
Early Stage Venture
Number Of Exists:
Series B
Technology:
Anti-infective Drugs
Last Funding Type:
Series B
Founded Date:
2012
Total Funding:
$47M